BioMarin Announces Appointment of Ian T. Clark to Board of Directors
1. BioMarin appointed Ian T. Clark to its Board of Directors. 2. Clark's experience includes leadership at Genentech, launching 15 new drugs. 3. He has over three decades of biopharmaceutical experience and governance. 4. Clark looks to advance BioMarin's mission for genetically defined conditions. 5. BioMarin has a strong clinical pipeline, focusing on rare genetic conditions.